Literature DB >> 20703450

Relapse to smoking during unaided cessation: clinical, cognitive and motivational predictors.

Jane Powell1, Lynne Dawkins, Robert West, John Powell, Alan Pickering.   

Abstract

RATIONALE: Neurobiological models of addiction suggest that abnormalities of brain reward circuitry distort salience attribution and inhibitory control processes, which in turn contribute to high relapse rates.
OBJECTIVES: The aim of this study is to determine whether impairments of salience attribution and inhibitory control predict relapse in a pharmacologically unaided attempt at smoking cessation.
METHODS: One hundred forty one smokers were assessed on indices of nicotine consumption/dependence (e.g. The Fagerström Test of Nicotine Dependence, cigarettes per day, salivary cotinine) and three trait impulsivity measures. After overnight abstinence, they completed experimental tests of cue reactivity, attentional bias to smoking cues, response to financial reward, motor impulsiveness and response inhibition (antisaccades). They then started a quit attempt with follow-up after 7 days, 1 month and 3 months; abstinence was verified via salivary cotinine levels ≤20 ng/ml.
RESULTS: Relapse rates at each point were 52.5%, 64% and 76.3%. The strongest predictor was pre-cessation salivary cotinine; other smoking/dependence indices did not explain additional outcome variance and neither did trait impulsivity. All experimental indices except responsivity to financial reward significantly predicted a 1-week outcome. Salivary cotinine, attentional bias to smoking cues and antisaccade errors explained unique as well as shared variance. At 1 and 3 months, salivary cotinine, motor impulsiveness and cue reactivity were all individually predictive; the effects of salivary cotinine and motor impulsiveness were additive.
CONCLUSIONS: These data provide some support for the involvement of abnormal cognitive and motivational processes in sustaining smoking dependence and suggest that they might be a focus of interventions, especially in the early stages of cessation.

Entities:  

Mesh:

Year:  2010        PMID: 20703450     DOI: 10.1007/s00213-010-1975-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  76 in total

1.  Meta-analysis of cue-reactivity in addiction research.

Authors:  B L Carter; S T Tiffany
Journal:  Addiction       Date:  1999-03       Impact factor: 6.526

2.  Correlations between orbitofrontal dysfunction and tobacco smoking.

Authors:  Marcello Spinella
Journal:  Addict Biol       Date:  2002-10       Impact factor: 4.280

3.  Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse.

Authors:  Sharon Dawe; Matthew J Gullo; Natalie J Loxton
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

4.  A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation.

Authors:  Lynne Dawkins; Jane H Powell; Robert West; John Powell; Alan Pickering
Journal:  Psychopharmacology (Berl)       Date:  2006-10-18       Impact factor: 4.530

5.  Personality traits associated with caffeine intake and smoking.

Authors:  Manuel Gurpegui; Dolores Jurado; Juan D Luna; Carmen Fernández-Molina; Obdulia Moreno-Abril; Ramón Gálvez
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-02-15       Impact factor: 5.067

6.  The role of self-reported impulsivity and reward sensitivity versus neurocognitive measures of disinhibition and decision-making in the prediction of relapse in pathological gamblers.

Authors:  A E Goudriaan; J Oosterlaan; E De Beurs; W Van Den Brink
Journal:  Psychol Med       Date:  2007-05-14       Impact factor: 7.723

7.  Saliva cotinine as a measure of smoking status in field settings.

Authors:  D B Abrams; M J Follick; L Biener; K B Carey; J Hitti
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

8.  Regional brain activity correlates of nicotine dependence.

Authors:  Jed E Rose; Frederique M Behm; Alfred N Salley; James E Bates; R Edward Coleman; Thomas C Hawk; Timothy G Turkington
Journal:  Neuropsychopharmacology       Date:  2007-03-14       Impact factor: 7.853

9.  Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM).

Authors:  Megan E Piper; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Caryn Lerman; Neal Benowitz; Michael C Fiore; Timothy B Baker
Journal:  Nicotine Tob Res       Date:  2008-06       Impact factor: 4.244

10.  Measures of abstinence in clinical trials: issues and recommendations.

Authors:  John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan
Journal:  Nicotine Tob Res       Date:  2003-02       Impact factor: 4.244

View more
  79 in total

1.  Subjective reactivity to smoking cues as a predictor of quitting success.

Authors:  Kenneth A Perkins
Journal:  Nicotine Tob Res       Date:  2011-12-01       Impact factor: 4.244

Review 2.  Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian; Samuel M McClure
Journal:  Psychopharmacology (Berl)       Date:  2012-03-24       Impact factor: 4.530

Review 3.  Cognitive enhancement as a treatment for drug addictions.

Authors:  Mehmet Sofuoglu; Elise E DeVito; Andrew J Waters; Kathleen M Carroll
Journal:  Neuropharmacology       Date:  2012-06-23       Impact factor: 5.250

4.  Attentional bias to drug cues is elevated before and during temptations to use heroin and cocaine.

Authors:  Andrew J Waters; Reshmi Marhe; Ingmar H A Franken
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

5.  Does laboratory cue reactivity correlate with real-world craving and smoking responses to cues?

Authors:  Saul Shiffman; Xiaoxue Li; Michael S Dunbar; Hilary A Tindle; Sarah M Scholl; Stuart G Ferguson
Journal:  Drug Alcohol Depend       Date:  2015-07-29       Impact factor: 4.492

6.  Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study.

Authors:  Rebecca L Ashare; Riju Ray; Caryn Lerman; Andrew A Strasser
Journal:  Drug Alcohol Depend       Date:  2012-05-15       Impact factor: 4.492

7.  Neural Signatures of Cognitive Flexibility and Reward Sensitivity Following Nicotinic Receptor Stimulation in Dependent Smokers: A Randomized Trial.

Authors:  Elise Lesage; Sarah E Aronson; Matthew T Sutherland; Thomas J Ross; Betty Jo Salmeron; Elliot A Stein
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

8.  Dopamine, urges to smoke, and the relative salience of drug versus non-drug reward.

Authors:  Tom P Freeman; Ravi K Das; Sunjeev K Kamboj; H Valerie Curran
Journal:  Soc Cogn Affect Neurosci       Date:  2014-02-12       Impact factor: 3.436

9.  Implicit attitudes towards smoking predict long-term relapse in abstinent smokers.

Authors:  Adriaan Spruyt; Valentine Lemaigre; Bihiyga Salhi; Dinska Van Gucht; Helen Tibboel; Bram Van Bockstaele; Jan De Houwer; Jan Van Meerbeeck; Kristiaan Nackaerts
Journal:  Psychopharmacology (Berl)       Date:  2015-03-13       Impact factor: 4.530

Review 10.  Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.

Authors:  Samantha N Hellberg; Trinity I Russell; Mike J F Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.